Conceptio › Archive › ODU Digital Commons
ODU Digital Commons metadata only

A Real-World Characterization of Patients Receiving Biologics for Type 2 Inflammatory Diseases in a Tertiary Rhinology Practice

Marshall, T. Blaise et al.
ODU Digital Commons · Papers
Open Source ↗
allergy-and-immunologyasthmamedicine-and-health-sciencesmonoclonal-antibodies
Background: Biologic therapies, such as omalizumab, mepolizumab, dupilumab, and benralizumab, are increasingly used in the treatment of various type 2 inflammatory diseases, including chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma, and atopic dermatitis. While these biologic therapies
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1221313
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive